Purpose The administration of topical tacrolimus (FK506) eye drops or ointment is used in treating corneal immune pathologies and in the prevention of the high‐risk corneal graft rejection. The purpose of this study is to develop a new well‐tolerated formulation of tacrolimus 0,06% eye drops. Procedure and the preparation are presented and discussed.
Methods Tacrolimus monohydrate powder and virgin castor oil are used in this new formulation. The manufacturing process guarantees the product sterility. Analytical validation of the assay by high‐performance liquid chromatography allows precise control of the concentration of tacrolimus.
Results The manufacturing and packaging of these eye drops provide good product stability. The concentration of tacrolimus 0.06% was maintained for 28 days, and no mycological or bacteriological contamination was found. Eye drop can be conserved close and exposed to the light during three months after production.
Conclusion Tolerance studies are currently being carried out.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.